Join us for Episode 20 of NETCast. Today we are excited to bring a live taping from the NET Regional Education Conference, at U Miami Health and jointly provided by Sylvester Comprehensive Cancer Center and NANETS.

Our guest moderator is Aman Chuahan, MD, is a medical oncologist at University of Miami, Leader of the Neuroendocrine Cancer Program and co-leader of the Diagnostic Drug Development program at Sylvester Comprehensive Cancer Center, and Co-Chair of NANETS Communications Committee.

He is joined by guest participants who attended ENETS and will share some of their impressions:

Jaydira del Rivero, MD, Asst. Research Physician and Director Rare Tumor Clinic, Center for Cancer Research, National Cancer Institute, and member of NANETS’ Executive Board of Directors;

Thorvardur Halfdanarson, MD, Medical Oncology, Associate Professor, Mayo Clinic, President, NANETS Board of Directors; and

Simron Singh, MD, MPH, FRCPC, Medical Oncologist, Odette Cancer Center at Sunnybrook Health Sciences Center, Adjunct Professor, University of Toronto, and Secretary of NANETS’ Board of Directors.

Today’s topic is sure to engage many of you who were unable to attend the ENETS conference, and many of you who will want to tune in to hear about things you may have missed at the conference!

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Dr. Jason Starr. medical oncologist with Mayo Clinic, and Chair of NANETS Communications Committee, talks with NANETS Communications Director Maureen Werther about their goals and projects planned for 2024. Collaboration is the key focal point in '24. Tune in and learn about upcoming webinars, podcasts, programs and events that will be hosted jointly with our partners in the neuroendocrine field.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Simron Singh is a medical oncologist, affiliate scientist in the Odette Cancer Research Program at Sunnybrook Research Institute, and an assistant professor at the University of Toronto. Dr. Singh is a longtime member of NANETS and the current Treasurer of its Board of Directors.

Dr. Alexandria T. Phan is a Professor of Internal Medicine and Medical Oncology at Froedtert & Medical College of Wisconsin, with a special focus on neuroendocrine tumors and malignancies of the GI tract. Dr. Phan is a member of NANETS' Communications and the moderator of this discussion. The doctors will discuss highlights from the recent ASCO meeting, with a special focus on the results of the phase 3 randomized NETTER-2 study. This is the first randomized study to demonstrate efficacy of RLT as 1L treatment in any malignancy and will change clinical practice.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.